0000950123-11-082088.txt : 20110901 0000950123-11-082088.hdr.sgml : 20110901 20110901162649 ACCESSION NUMBER: 0000950123-11-082088 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20110901 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20110901 DATE AS OF CHANGE: 20110901 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMSURG CORP CENTRAL INDEX KEY: 0000895930 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 621493316 STATE OF INCORPORATION: TN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-22217 FILM NUMBER: 111071318 BUSINESS ADDRESS: STREET 1: 20 BURTON HILLS BLVD. STREET 2: SUITE 500 CITY: NASHVILLE STATE: TN ZIP: 37215 BUSINESS PHONE: 615-665-1283 MAIL ADDRESS: STREET 1: 20 BURTON HILLS BLVD. STREET 2: SUITE 500 CITY: NASHVILLE STATE: TN ZIP: 37215 8-K 1 g28059e8vk.htm FORM 8-K e8vk
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 1, 2011 (September 1, 2011)
AMSURG CORP.
(Exact Name of Registrant as Specified in Charter)
         
Tennessee
(State or Other Jurisdiction of
Incorporation)
  000-22217
(Commission
File Number)
  62-1493316
(I.R.S. Employer
Identification No.)
     
20 Burton Hills Boulevard    
Nashville, Tennessee
(Address of Principal Executive Offices)
  37215
(Zip Code)
(615) 665-1283
(Registrant’s Telephone Number, Including Area Code)
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 


 

Item 7.01.   Regulation FD Disclosure
     On September 1, 2011, AmSurg Corp. issued a press release, the text of which is set forth as Exhibit 99.
Item 9.01.   Financial Statements and Exhibits
     (c) 99 Press release dated September 1, 2011

2


 

SIGNATURES
     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
  AMSURG CORP.
 
 
  By:   /s/ Claire M. Gulmi    
    Claire M. Gulmi   
    Executive Vice President and Chief Financial Officer (Principal Financial and Duly Authorized Officer)   
 
Date: September 1, 2011

3


 

INDEX TO EXHIBITS
         
Exhibit    
Number   Description
  99    
Press release dated September 1, 2011

4

EX-99 2 g28059exv99.htm EX-99 exv99
Exhibit 99
Press Release
         
 
  Contact:   Claire M. Gulmi
Executive Vice President and
Chief Financial Officer
(615) 665-1283
AMSURG CORP. TO PRESENT AT
BAIRD’S 2011 HEALTH CARE CONFERENCE
NASHVILLE, Tenn. — (September 1, 2011) — AmSurg Corp. (NASDAQ: AMSG) today announced that it will participate in the Baird’s 2011 Health Care Conference on Thursday, September 8, in New York City. In connection with the conference, there will be an on-line simulcast and a replay of the presentation available at the Company’s web site starting at 2:45 p.m. Eastern Time / 1:45 p.m. Central Time. Christopher A. Holden, President and Chief Executive Officer, and Kevin Eastridge, Senior Vice President, Finance and Chief Accounting Officer, will be speaking at the conference.
     The live audio webcast and replay of the presentation will be available on the Company’s website by going to www.amsurg.com and clicking on Investors. For the live audio, please go to the site at least 15 minutes prior to the presentation to download and install any necessary audio software. The webcast replay will be available for 30 days.
     AmSurg Corp. acquires, develops and operates ambulatory surgery centers in partnership with physician practice groups throughout the United States. At June 30, 2011, AmSurg owned a majority interest in 208 continuing centers in operation and had one center under development.
- END -